These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37187037)

  • 1. Ultrasound-induced seizures in a mouse model of KCNQ2-NEO-DEE.
    Brun L; Borloz E; Felix MS; Louis Durand J; Villard L
    Epilepsy Res; 2023 Jul; 193():107160. PubMed ID: 37187037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A knock-in mouse model for KCNQ2-related epileptic encephalopathy displays spontaneous generalized seizures and cognitive impairment.
    Milh M; Roubertoux P; Biba N; Chavany J; Spiga Ghata A; Fulachier C; Collins SC; Wagner C; Roux JC; Yalcin B; Félix MS; Molinari F; Lenck-Santini PP; Villard L
    Epilepsia; 2020 May; 61(5):868-878. PubMed ID: 32239694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capturing seizures in clinical trials of antiseizure medications for
    Millichap JJ; Harden CL; Dlugos DJ; French JA; Butterfield NN; Grayson C; Aycardi E; Pimstone SN
    Epilepsia Open; 2021 Mar; 6(1):38-44. PubMed ID: 33681646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ezogabine impacts seizures and development in patients with KCNQ2 developmental and epileptic encephalopathy.
    Knight D; Mahida S; Kelly M; Poduri A; Olson HE
    Epilepsia; 2023 Jul; 64(7):e143-e147. PubMed ID: 37096745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epilepsy phenotype and response to KCNQ openers in mice harboring the Kcnq2 R207W voltage-sensor mutation.
    Tian F; Cao B; Xu H; Zhan L; Nan F; Li N; Taglialatela M; Gao Z
    Neurobiol Dis; 2022 Nov; 174():105860. PubMed ID: 36113748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse models of Kcnq2 dysfunction.
    Brun L; Viemari JC; Villard L
    Epilepsia; 2022 Nov; 63(11):2813-2826. PubMed ID: 36047730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of KCNQ2 encephalopathy.
    Kim HJ; Yang D; Kim SH; Won D; Kim HD; Lee JS; Choi JR; Lee ST; Kang HC
    Brain Dev; 2021 Feb; 43(2):244-250. PubMed ID: 32917465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted gene panel sequencing in early infantile onset developmental and epileptic encephalopathy.
    Na JH; Shin S; Yang D; Kim B; Kim HD; Kim S; Lee JS; Choi JR; Lee ST; Kang HC
    Brain Dev; 2020 Jun; 42(6):438-448. PubMed ID: 32139178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiepileptic therapy approaches in KCNQ2 related epilepsy: A systematic review.
    Kuersten M; Tacke M; Gerstl L; Hoelz H; Stülpnagel CV; Borggraefe I
    Eur J Med Genet; 2020 Jan; 63(1):103628. PubMed ID: 30771507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Time-limited alterations in cortical activity of a knock-in mouse model of KCNQ2-related developmental and epileptic encephalopathy.
    Biba-Maazou N; Becq H; Pallesi-Pocachard E; Sarno S; Granjeaud S; Montheil A; Kurz M; Villard L; Milh M; Santini PL; Aniksztejn L
    J Physiol; 2022 May; 600(10):2429-2460. PubMed ID: 35389519
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship Between Epileptic Activity and Developmental Outcome in KCNQ2-Related Epilepsy.
    Casas-Alba D; Aguilar A; Alonso I; García MT; Cilio MR; Fons C;
    Pediatr Neurol; 2023 Jul; 144():11-15. PubMed ID: 37099824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and genetic analysis of 18 patients with
    Cao B; Peng B; Tian Y; Wang X; Li X; Zhu H; Shen H; Chen W
    Turk J Pediatr; 2024 May; 66(2):191-204. PubMed ID: 38814296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and genetic analysis of 23 Chinese children with epilepsy associated with KCNQ2 gene mutations.
    Yu X; Che F; Zhang X; Yang L; Zhu L; Xu N; Qiu S; Li Y
    Epilepsia Open; 2024 Oct; 9(5):1658-1669. PubMed ID: 39141400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics of KCNQ2 variants causing either benign neonatal epilepsy or developmental and epileptic encephalopathy.
    Goto A; Ishii A; Shibata M; Ihara Y; Cooper EC; Hirose S
    Epilepsia; 2019 Sep; 60(9):1870-1880. PubMed ID: 31418850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroconvulsive seizure thresholds and kindling acquisition rates are altered in mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions.
    Otto JF; Singh NA; Dahle EJ; Leppert MF; Pappas CM; Pruess TH; Wilcox KS; White HS
    Epilepsia; 2009 Jul; 50(7):1752-9. PubMed ID: 19453707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization.
    Singh NA; Otto JF; Dahle EJ; Pappas C; Leslie JD; Vilaythong A; Noebels JL; White HS; Wilcox KS; Leppert MF
    J Physiol; 2008 Jul; 586(14):3405-23. PubMed ID: 18483067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus.
    Hawkins NA; Martin MS; Frankel WN; Kearney JA; Escayg A
    Neurobiol Dis; 2011 Mar; 41(3):655-60. PubMed ID: 21156207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe epilepsy resulting from genetic interaction between Scn2a and Kcnq2.
    Kearney JA; Yang Y; Beyer B; Bergren SK; Claes L; Dejonghe P; Frankel WN
    Hum Mol Genet; 2006 Mar; 15(6):1043-8. PubMed ID: 16464983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pyridoxine-responsive KCNQ2 epileptic encephalopathy: Additional cases and literature review.
    Chen J; Tao Q; Fan L; Shen Y; Liu J; Luo H; Yang Z; Liang M; Gan J
    Mol Genet Genomic Med; 2022 Oct; 10(10):e2024. PubMed ID: 35906921
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.